Region MidtJylland Denmark Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2017
NCT04376216
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Frank Mose | Hospitalsapoteket Region Midtjylland | Region MidtJylland Denmark | Region Midtjyllands Psykiatriske Forskningsfond | Region midtjyllands sundhedsvidenskabelige forskningsfond

Active Ingredients

Drugs in Phase 4 Trials (2)

prednisone (meticorten) (1 trial)

thiamine (1 trial)

Drugs in Other Trials (3)

potassium chloride (klor-con) (1 trial)

potassium nitrate (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Nephritis (Phase 4)

Nephritis, Interstitial (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5